News
The London Biotechnology Show returns for its highly anticipated second edition, building on the remarkable success of its ...
Discover how gene editing and lab-grown meat are revolutionising healthcare and food in 2025, offering personalised ...
The regenerative medicine market is an exciting and rapidly evolving sector within the healthcare industry. This market focuses on the development and application of therapies and technologies ...
Scientists analyzed almost 200 cannabis genomes to create the most comprehensive, high-quality, detailed genetic atlas of the plant to date. The atlas reveals unprecedented diversity and complexity ...
Absci has entered the clinic with its AI-designed antibody, dosing first volunteers in a trial targeting TL1A for ...
These findings have the potential to pave the way for new advances in medicine, agriculture and biotechnology in helping scientists to design proteins that can multitask more efficiently ...
VOV.VN - The unique values of Vietnam’s traditional medicine drew significant attention at the International Congress on ...
This will open doors for new advances in medicine, agriculture, and biotechnology by helping scientists design proteins that can multitask more efficiently. “Two structurally identical plant ...
2d
News-Medical.Net on MSNSalk researchers create detailed genetic atlas of cannabis to dateCannabis has been a globally important crop for millennia. While best known today as marijuana for its psychoactive ...
Latus Bio, Inc. (Latus), a biotechnology company pioneering advances in AAV gene therapy, has announced new research published today in Science Translational Medicine, “AAVs engineered for robust ...
PDS Biotechnology Corp (NASDAQ ... A: Dr. Kirk Shepard, Chief Medical Officer, explained that the KEYNOTE-689 trial primarily involved HPV negative patients, with only 3% to 4% being HPV positive.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results